At a glance

Endometrial protection (HRT)
Pregnancy / fertility support
Sleep & anxiety support
Menstrual cycle regulation
Blood clot / cardiovascular risk
Drowsiness / cognitive effects
Long-term cancer risk (breast)
BenefitSide effectHealth risk· more & brighter bars = stronger

Effects

  • Endometrial protection: Converts oestrogen-primed endometrium to a secretory state, preventing hyperplasia and protecting against endometrial cancer when used alongside oestrogen HRT [2].
  • Pregnancy support: Prevents endometrial shedding, reduces uterine contractility, and modulates immune tolerance to support implantation and early pregnancy [6].
  • Anxiolytic / sleep support: Oral micronised progesterone is metabolised to allopregnanolone, a GABA-A receptor agonist, producing mild sedative, anxiolytic, and sleep-promoting effects [5].
  • Menstrual regulation: Used to manage secondary amenorrhea and dysfunctional uterine bleeding by restoring a normal secretory phase and allowing controlled withdrawal bleeding [2].
  • Neuroprotection (emerging): Progesterone and its metabolites are under investigation as neuroprotectors and immunomodulators, though clinical evidence remains preliminary [1].
Classification

Endogenous progestogen / steroid hormone

Active half-life

~13–25 h (route-dependent; oral ~1–2 h peak, vaginal ~6 h peak, absorption t½ 25–50 h for gel)

Route

Oral (micronised capsule), vaginal (gel / pessary), intramuscular injection, transdermal (compounded)

Schedule

Prescription-only (FDA Rx); not a DEA scheduled substance

Onset

Oral: peak ~1–2 h; vaginal: peak ~6 h; effect on endometrium within days